← All trials
NCT00992745
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2009
- Primary completion
- Sep 1, 2011
- Completion date
- Sep 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 24
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Molecular Insight PharmaceuticalsLead sponsor
- Duke UniversityOverall official - principal investigator
- University of MarylandOverall official - principal investigator
- University of California, San FranciscoOverall official - principal investigator
- Pacific Coast ImagingOverall official - principal investigator
- Vanguard Urologic Research FoundationOverall official - principal investigator
- West Coast Radiology CenterseOverall official - principal investigator
- Cornell UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.